Trokendi XR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 17772-101
  • Package NDC 17772-101-01
  • Package NDC 17772-101-07
  • Package NDC 17772-101-10
  • Package NDC 17772-101-12
  • Package NDC 17772-101-30
  • Application number NDA201635
  • SPL ID 5d1a1ba0-75c6-2714-e063-6294a90a362c
  • SPL set ID 2dc7957e-a3e5-46bb-aa66-f3250f872f5e
  • UNII 0H73WJJ391
  • RxCUI 1436239
  • RxCUI 1436245
  • RxCUI 1437278
  • RxCUI 1437280
  • RxCUI 1437283
  • RxCUI 1437285
  • RxCUI 1437288
  • RxCUI 1437290

What the source publishes

Labeler
Supernus Pharmaceuticals, Inc.
Active ingredients
topiramate
Form
CAPSULE, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:17772-101_5d1a1ba0-75c6-2714-e063-6294a90a362c
{
  "name": "Trokendi XR",
  "splId": "5d1a1ba0-75c6-2714-e063-6294a90a362c",
  "labels": [
    {
      "setId": "2dc7957e-a3e5-46bb-aa66-f3250f872f5e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc7957e-a3e5-46bb-aa66-f3250f872f5e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2dc7957e-a3e5-46bb-aa66-f3250f872f5e"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Supernus Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-01)",
      "package_ndc": "17772-101-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20130816"
    },
    {
      "sample": true,
      "description": "7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-07)",
      "package_ndc": "17772-101-07",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200623"
    },
    {
      "sample": true,
      "description": "5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-10)",
      "package_ndc": "17772-101-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20130816"
    },
    {
      "sample": true,
      "description": "7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-101-12)",
      "package_ndc": "17772-101-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20130816"
    },
    {
      "sample": false,
      "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-30)",
      "package_ndc": "17772-101-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20130816"
    }
  ],
  "productId": "17772-101_5d1a1ba0-75c6-2714-e063-6294a90a362c",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE, EXTENDED RELEASE",
  "productNdc": "17772-101",
  "deaSchedule": null,
  "genericName": "topiramate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TOPIRAMATE",
      "strength": "25 mg/1"
    }
  ],
  "applicationNumber": "NDA201635",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20130816",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008486",
      "N0000185506",
      "N0000182140"
    ],
    "upc": [
      "0317772101300",
      "0317772102307",
      "0317772104301",
      "0317772103304"
    ],
    "unii": [
      "0H73WJJ391"
    ],
    "rxcui": [
      "1436239",
      "1436245",
      "1437278",
      "1437280",
      "1437283",
      "1437285",
      "1437288",
      "1437290"
    ],
    "spl_set_id": [
      "2dc7957e-a3e5-46bb-aa66-f3250f872f5e"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 3A4 Inducers [MoA]",
      "Cytochrome P450 2C19 Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Supernus Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:17772-101_5d1a1ba0-75c6-2714-e063-6294a90a362c"